Species Adulteration in the Herbal Trade: Causes, Consequences and Mitigation
Ramanujam Srirama,
J. U. Santhosh Kumar,
G. S. Seethapathy,
Steven G. Newmaster,
S. Ragupathy,
K. N. Ganeshaiah,
R. Uma Shaanker and
Gudasalamani Ravikanth ()
Additional contact information
Ramanujam Srirama: Ashoka Trust for Research in Ecology and the Environment
J. U. Santhosh Kumar: University of Agricultural Sciences, GKVK
G. S. Seethapathy: Ashoka Trust for Research in Ecology and the Environment
Steven G. Newmaster: University of Guelph
S. Ragupathy: University of Guelph
K. N. Ganeshaiah: Ashoka Trust for Research in Ecology and the Environment
R. Uma Shaanker: Ashoka Trust for Research in Ecology and the Environment
Gudasalamani Ravikanth: Ashoka Trust for Research in Ecology and the Environment
Drug Safety, 2017, vol. 40, issue 8, No 2, 661 pages
Abstract:
Abstract The global economy of the international trade of herbal products has been increasing by 15% annually, with the raw material for most herbal products being sourced from South and Southeast Asian countries. In India, of the 8000 species of medicinal plants harvested from the wild, approximately 960 are in the active trade. With increasing international trade in herbal medicinal products, there is also increasing concern about the widespread adulteration and species admixtures in the raw herbal trade. The adverse consequences of such species adulteration on the health and safety of consumers have only recently begun to be recognised and documented. We provide a comprehensive review of the nature and magnitude of species adulteration in the raw herbal trade, and identify the underlying drivers that might lead to such adulteration. We also discuss the possible biological and chemical equivalence of species that are used as adulterants and substitutes, and the consequences thereof to consumer health and safety, and propose a framework for the development of a herbal trade authentication service that can help regulate the herbal trade market.
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:
Downloads: (external link)
http://link.springer.com/10.1007/s40264-017-0527-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0527-0
Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264
DOI: 10.1007/s40264-017-0527-0
Access Statistics for this article
Drug Safety is currently edited by Nitin Joshi
More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().